Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Aura Biosciences, Inc.’s reported figures.
Plus components not separately reported this period.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
FAQ
- What is Aura Biosciences, Inc.'s EBIT?
- Aura Biosciences, Inc. (AURA) reported EBIT of -$34.87M in Q1 2026.
- How has Aura Biosciences, Inc.'s EBIT changed year-over-year?
- Aura Biosciences, Inc.'s EBIT decreased by 20.1% year-over-year, from -$29.04M to -$34.87M.
- What is the long-term trend for Aura Biosciences, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s EBIT has grown at a 33.7% compound annual growth rate (CAGR), from -$35.25M to -$112.79M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Aura Biosciences, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude